Federal Register Notices > Rules - 1999

Rules - 1999

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

DRUG SCHEDULING ACTIONS

• Placement of Zaleplon into Schedule IV (September 13, 1999)  
• Rescheduling of the Food and Drug Administration Approved Product Containing Synthetic Dronabinol [(-)-D⁹-(trans)-Tetrahydrocannabinol] in Sesame Oil and Encapsulated in Soft Gelatin Capsules From Schedule II to Schedule III - Correction  (August 4, 1999)  
• Placement of Ketamine into Schedule III - Correction (July 22, 1999)  
• Placement of Ketamine into Schedule III (July 13, 1999)  
• Rescheduling of the Food and Drug Administration Approved Product Containing Synthetic Dronabinol [(-)-D⁹-(trans)-Tetrahydrocannabinol] in Sesame Oil and Encapsulated in Soft Gelatin Capsules From Schedule II to Schedule III  (July 2, 1999)  
• Proposed Placement of Zaleplon into Schedule IV - Correction (May 11, 1999)  
• Proposed Placement of Zaleplon Into Schedule IV (May 5, 1999)  
• Proposed Placement of Ketamine Into Schedule III (April 9, 1999)  
• Proposed Placement of Ketamine Into Schedule III (April 9, 1999)

REGISTRATION / RECORD KEEPING / REPORTING

• Chemical Registration and Reregistration Fees - Correction (December 16, 1999)  
• Chemical Registration and Reregistration Fees (December 1, 1999)  
• Temporary Exemption From Chemical Registration for Distributors of Pseudoephedrine and Phenylpropanolamine Products (July 27, 1999)